nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbachol—PLA2G4A—Epirubicin—hematologic cancer	0.355	1	CbGbCtD
Carbachol—PLA2G4A—Raltitrexed—Methotrexate—hematologic cancer	0.00386	0.604	CbGdCrCtD
Carbachol—Choline—PDE4B—hematologic cancer	0.00278	0.56	CrCbGaD
Carbachol—Choline—SLC22A1—hematologic cancer	0.00219	0.44	CrCbGaD
Carbachol—PLA2G4A—Betamethasone—Dexamethasone—hematologic cancer	0.000332	0.0519	CbGdCrCtD
Carbachol—PLA2G4A—Dexamethasone—Betamethasone—hematologic cancer	0.000332	0.0519	CbGdCrCtD
Carbachol—PLA2G4A—Betamethasone—Triamcinolone—hematologic cancer	0.000325	0.0508	CbGdCrCtD
Carbachol—PLA2G4A—Dexamethasone—Triamcinolone—hematologic cancer	0.000325	0.0508	CbGdCrCtD
Carbachol—PLA2G4A—Dexamethasone—Prednisone—hematologic cancer	0.000308	0.0482	CbGdCrCtD
Carbachol—PLA2G4A—Betamethasone—Prednisone—hematologic cancer	0.000308	0.0482	CbGdCrCtD
Carbachol—PLA2G4A—Betamethasone—Prednisolone—hematologic cancer	0.000301	0.047	CbGdCrCtD
Carbachol—PLA2G4A—Dexamethasone—Prednisolone—hematologic cancer	0.000301	0.047	CbGdCrCtD
Carbachol—Abdominal pain—Alitretinoin—hematologic cancer	0.000232	0.000525	CcSEcCtD
Carbachol—Body temperature increased—Alitretinoin—hematologic cancer	0.000232	0.000525	CcSEcCtD
Carbachol—Abdominal discomfort—Methotrexate—hematologic cancer	0.000231	0.000523	CcSEcCtD
Carbachol—Rash—Hydroxyurea—hematologic cancer	0.000231	0.000523	CcSEcCtD
Carbachol—Dermatitis—Hydroxyurea—hematologic cancer	0.00023	0.000522	CcSEcCtD
Carbachol—Headache—Hydroxyurea—hematologic cancer	0.000229	0.000519	CcSEcCtD
Carbachol—Pain—Gemcitabine—hematologic cancer	0.000229	0.000519	CcSEcCtD
Carbachol—Abdominal pain—Ifosfamide—hematologic cancer	0.000229	0.000519	CcSEcCtD
Carbachol—Body temperature increased—Ifosfamide—hematologic cancer	0.000229	0.000519	CcSEcCtD
Carbachol—Diarrhoea—Vinorelbine—hematologic cancer	0.000228	0.000517	CcSEcCtD
Carbachol—Syncope—Triamcinolone—hematologic cancer	0.000228	0.000516	CcSEcCtD
Carbachol—Infection—Etoposide—hematologic cancer	0.000227	0.000515	CcSEcCtD
Carbachol—Nausea—Melphalan—hematologic cancer	0.000227	0.000514	CcSEcCtD
Carbachol—Dizziness—Bortezomib—hematologic cancer	0.000226	0.000512	CcSEcCtD
Carbachol—Asthma—Epirubicin—hematologic cancer	0.000225	0.000511	CcSEcCtD
Carbachol—Loss of consciousness—Triamcinolone—hematologic cancer	0.000223	0.000506	CcSEcCtD
Carbachol—Abdominal pain—Vincristine—hematologic cancer	0.000223	0.000506	CcSEcCtD
Carbachol—Body temperature increased—Vincristine—hematologic cancer	0.000223	0.000506	CcSEcCtD
Carbachol—Shock—Prednisolone—hematologic cancer	0.000222	0.000503	CcSEcCtD
Carbachol—Hyperhidrosis—Etoposide—hematologic cancer	0.000221	0.000501	CcSEcCtD
Carbachol—Dizziness—Vinorelbine—hematologic cancer	0.00022	0.0005	CcSEcCtD
Carbachol—Nausea—Lenalidomide—hematologic cancer	0.00022	0.000499	CcSEcCtD
Carbachol—Hyperhidrosis—Prednisolone—hematologic cancer	0.000218	0.000494	CcSEcCtD
Carbachol—Diarrhoea—Thiotepa—hematologic cancer	0.000218	0.000494	CcSEcCtD
Carbachol—Body temperature increased—Mitoxantrone—hematologic cancer	0.000217	0.000492	CcSEcCtD
Carbachol—Abdominal pain—Irinotecan—hematologic cancer	0.000217	0.000492	CcSEcCtD
Carbachol—Abdominal pain—Mitoxantrone—hematologic cancer	0.000217	0.000492	CcSEcCtD
Carbachol—Body temperature increased—Irinotecan—hematologic cancer	0.000217	0.000492	CcSEcCtD
Carbachol—Nausea—Hydroxyurea—hematologic cancer	0.000217	0.000492	CcSEcCtD
Carbachol—Vomiting—Bortezomib—hematologic cancer	0.000217	0.000492	CcSEcCtD
Carbachol—Vomiting—Bleomycin—hematologic cancer	0.000215	0.000488	CcSEcCtD
Carbachol—Rash—Bortezomib—hematologic cancer	0.000215	0.000488	CcSEcCtD
Carbachol—Dermatitis—Bortezomib—hematologic cancer	0.000215	0.000487	CcSEcCtD
Carbachol—Flushing—Prednisone—hematologic cancer	0.000214	0.000485	CcSEcCtD
Carbachol—Headache—Bortezomib—hematologic cancer	0.000214	0.000485	CcSEcCtD
Carbachol—Hypotension—Etoposide—hematologic cancer	0.000214	0.000484	CcSEcCtD
Carbachol—Rash—Bleomycin—hematologic cancer	0.000214	0.000484	CcSEcCtD
Carbachol—Pain—Cisplatin—hematologic cancer	0.000213	0.000484	CcSEcCtD
Carbachol—Dermatitis—Bleomycin—hematologic cancer	0.000213	0.000484	CcSEcCtD
Carbachol—Vomiting—Vinorelbine—hematologic cancer	0.000212	0.00048	CcSEcCtD
Carbachol—Body temperature increased—Gemcitabine—hematologic cancer	0.000212	0.00048	CcSEcCtD
Carbachol—Diarrhoea—Thalidomide—hematologic cancer	0.000211	0.000477	CcSEcCtD
Carbachol—Dizziness—Thiotepa—hematologic cancer	0.000211	0.000477	CcSEcCtD
Carbachol—Rash—Vinorelbine—hematologic cancer	0.00021	0.000476	CcSEcCtD
Carbachol—Dermatitis—Vinorelbine—hematologic cancer	0.00021	0.000476	CcSEcCtD
Carbachol—Headache—Vinorelbine—hematologic cancer	0.000209	0.000473	CcSEcCtD
Carbachol—Asthma—Doxorubicin—hematologic cancer	0.000209	0.000473	CcSEcCtD
Carbachol—Syncope—Dexamethasone—hematologic cancer	0.000207	0.000469	CcSEcCtD
Carbachol—Syncope—Betamethasone—hematologic cancer	0.000207	0.000469	CcSEcCtD
Carbachol—Arrhythmia—Prednisone—hematologic cancer	0.000206	0.000467	CcSEcCtD
Carbachol—Infection—Triamcinolone—hematologic cancer	0.000206	0.000467	CcSEcCtD
Carbachol—Sweating—Methotrexate—hematologic cancer	0.000206	0.000467	CcSEcCtD
Carbachol—Shock—Triamcinolone—hematologic cancer	0.000204	0.000462	CcSEcCtD
Carbachol—Dizziness—Thalidomide—hematologic cancer	0.000204	0.000461	CcSEcCtD
Carbachol—Nausea—Bortezomib—hematologic cancer	0.000203	0.00046	CcSEcCtD
Carbachol—Loss of consciousness—Betamethasone—hematologic cancer	0.000203	0.000459	CcSEcCtD
Carbachol—Loss of consciousness—Dexamethasone—hematologic cancer	0.000203	0.000459	CcSEcCtD
Carbachol—Vomiting—Thiotepa—hematologic cancer	0.000202	0.000459	CcSEcCtD
Carbachol—Diarrhoea—Carmustine—hematologic cancer	0.000202	0.000458	CcSEcCtD
Carbachol—Nausea—Bleomycin—hematologic cancer	0.000201	0.000456	CcSEcCtD
Carbachol—Rash—Thiotepa—hematologic cancer	0.000201	0.000455	CcSEcCtD
Carbachol—Dermatitis—Thiotepa—hematologic cancer	0.000201	0.000454	CcSEcCtD
Carbachol—Hyperhidrosis—Triamcinolone—hematologic cancer	0.000201	0.000454	CcSEcCtD
Carbachol—Diarrhoea—Alitretinoin—hematologic cancer	0.0002	0.000454	CcSEcCtD
Carbachol—Headache—Thiotepa—hematologic cancer	0.000199	0.000452	CcSEcCtD
Carbachol—Diarrhoea—Ifosfamide—hematologic cancer	0.000198	0.000449	CcSEcCtD
Carbachol—Nausea—Vinorelbine—hematologic cancer	0.000198	0.000449	CcSEcCtD
Carbachol—Body temperature increased—Cisplatin—hematologic cancer	0.000197	0.000447	CcSEcCtD
Carbachol—Vomiting—Thalidomide—hematologic cancer	0.000196	0.000444	CcSEcCtD
Carbachol—Dizziness—Carmustine—hematologic cancer	0.000196	0.000443	CcSEcCtD
Carbachol—Pain—Etoposide—hematologic cancer	0.000196	0.000443	CcSEcCtD
Carbachol—Rash—Thalidomide—hematologic cancer	0.000194	0.00044	CcSEcCtD
Carbachol—Dermatitis—Thalidomide—hematologic cancer	0.000194	0.00044	CcSEcCtD
Carbachol—Dizziness—Alitretinoin—hematologic cancer	0.000194	0.000439	CcSEcCtD
Carbachol—Diarrhoea—Vincristine—hematologic cancer	0.000193	0.000438	CcSEcCtD
Carbachol—Headache—Thalidomide—hematologic cancer	0.000193	0.000437	CcSEcCtD
Carbachol—Pain—Prednisolone—hematologic cancer	0.000193	0.000437	CcSEcCtD
Carbachol—Sweating—Epirubicin—hematologic cancer	0.000193	0.000437	CcSEcCtD
Carbachol—Dizziness—Ifosfamide—hematologic cancer	0.000191	0.000434	CcSEcCtD
Carbachol—Nausea—Thiotepa—hematologic cancer	0.000189	0.000428	CcSEcCtD
Carbachol—Diarrhoea—Mitoxantrone—hematologic cancer	0.000188	0.000426	CcSEcCtD
Carbachol—Diarrhoea—Irinotecan—hematologic cancer	0.000188	0.000426	CcSEcCtD
Carbachol—Vomiting—Carmustine—hematologic cancer	0.000188	0.000426	CcSEcCtD
Carbachol—Infection—Dexamethasone—hematologic cancer	0.000187	0.000424	CcSEcCtD
Carbachol—Infection—Betamethasone—hematologic cancer	0.000187	0.000424	CcSEcCtD
Carbachol—Dizziness—Vincristine—hematologic cancer	0.000187	0.000423	CcSEcCtD
Carbachol—Rash—Carmustine—hematologic cancer	0.000186	0.000423	CcSEcCtD
Carbachol—Dermatitis—Carmustine—hematologic cancer	0.000186	0.000422	CcSEcCtD
Carbachol—Vomiting—Alitretinoin—hematologic cancer	0.000186	0.000422	CcSEcCtD
Carbachol—Headache—Carmustine—hematologic cancer	0.000185	0.00042	CcSEcCtD
Carbachol—Shock—Dexamethasone—hematologic cancer	0.000185	0.00042	CcSEcCtD
Carbachol—Shock—Betamethasone—hematologic cancer	0.000185	0.00042	CcSEcCtD
Carbachol—Rash—Alitretinoin—hematologic cancer	0.000185	0.000419	CcSEcCtD
Carbachol—Dermatitis—Alitretinoin—hematologic cancer	0.000185	0.000418	CcSEcCtD
Carbachol—Vomiting—Ifosfamide—hematologic cancer	0.000184	0.000417	CcSEcCtD
Carbachol—Headache—Alitretinoin—hematologic cancer	0.000184	0.000416	CcSEcCtD
Carbachol—Diarrhoea—Gemcitabine—hematologic cancer	0.000183	0.000415	CcSEcCtD
Carbachol—Nausea—Thalidomide—hematologic cancer	0.000183	0.000414	CcSEcCtD
Carbachol—Dyspepsia—Triamcinolone—hematologic cancer	0.000183	0.000414	CcSEcCtD
Carbachol—Rash—Ifosfamide—hematologic cancer	0.000183	0.000414	CcSEcCtD
Carbachol—Dermatitis—Ifosfamide—hematologic cancer	0.000182	0.000413	CcSEcCtD
Carbachol—Hyperhidrosis—Dexamethasone—hematologic cancer	0.000182	0.000412	CcSEcCtD
Carbachol—Hyperhidrosis—Betamethasone—hematologic cancer	0.000182	0.000412	CcSEcCtD
Carbachol—Dizziness—Irinotecan—hematologic cancer	0.000182	0.000412	CcSEcCtD
Carbachol—Abdominal pain—Etoposide—hematologic cancer	0.000181	0.00041	CcSEcCtD
Carbachol—Body temperature increased—Etoposide—hematologic cancer	0.000181	0.00041	CcSEcCtD
Carbachol—Syncope—Prednisone—hematologic cancer	0.00018	0.000408	CcSEcCtD
Carbachol—Vomiting—Vincristine—hematologic cancer	0.00018	0.000407	CcSEcCtD
Carbachol—Sweating—Doxorubicin—hematologic cancer	0.000178	0.000404	CcSEcCtD
Carbachol—Rash—Vincristine—hematologic cancer	0.000178	0.000403	CcSEcCtD
Carbachol—Dermatitis—Vincristine—hematologic cancer	0.000178	0.000403	CcSEcCtD
Carbachol—Pain—Triamcinolone—hematologic cancer	0.000177	0.000402	CcSEcCtD
Carbachol—Headache—Vincristine—hematologic cancer	0.000177	0.000401	CcSEcCtD
Carbachol—Loss of consciousness—Prednisone—hematologic cancer	0.000177	0.0004	CcSEcCtD
Carbachol—Hypotension—Dexamethasone—hematologic cancer	0.000176	0.000398	CcSEcCtD
Carbachol—Hypotension—Betamethasone—hematologic cancer	0.000176	0.000398	CcSEcCtD
Carbachol—Nausea—Carmustine—hematologic cancer	0.000176	0.000398	CcSEcCtD
Carbachol—Vomiting—Irinotecan—hematologic cancer	0.000175	0.000396	CcSEcCtD
Carbachol—Vomiting—Mitoxantrone—hematologic cancer	0.000175	0.000396	CcSEcCtD
Carbachol—Nausea—Alitretinoin—hematologic cancer	0.000174	0.000394	CcSEcCtD
Carbachol—Rash—Irinotecan—hematologic cancer	0.000173	0.000393	CcSEcCtD
Carbachol—Rash—Mitoxantrone—hematologic cancer	0.000173	0.000393	CcSEcCtD
Carbachol—Dermatitis—Irinotecan—hematologic cancer	0.000173	0.000392	CcSEcCtD
Carbachol—Dermatitis—Mitoxantrone—hematologic cancer	0.000173	0.000392	CcSEcCtD
Carbachol—Headache—Mitoxantrone—hematologic cancer	0.000172	0.00039	CcSEcCtD
Carbachol—Headache—Irinotecan—hematologic cancer	0.000172	0.00039	CcSEcCtD
Carbachol—Nausea—Ifosfamide—hematologic cancer	0.000172	0.00039	CcSEcCtD
Carbachol—Diarrhoea—Cisplatin—hematologic cancer	0.000171	0.000387	CcSEcCtD
Carbachol—Vomiting—Gemcitabine—hematologic cancer	0.00017	0.000386	CcSEcCtD
Carbachol—Rash—Gemcitabine—hematologic cancer	0.000169	0.000383	CcSEcCtD
Carbachol—Dermatitis—Gemcitabine—hematologic cancer	0.000169	0.000382	CcSEcCtD
Carbachol—Headache—Gemcitabine—hematologic cancer	0.000168	0.00038	CcSEcCtD
Carbachol—Nausea—Vincristine—hematologic cancer	0.000168	0.00038	CcSEcCtD
Carbachol—Flushing—Epirubicin—hematologic cancer	0.000167	0.000379	CcSEcCtD
Carbachol—Dyspepsia—Betamethasone—hematologic cancer	0.000166	0.000375	CcSEcCtD
Carbachol—Dyspepsia—Dexamethasone—hematologic cancer	0.000166	0.000375	CcSEcCtD
Carbachol—Body temperature increased—Triamcinolone—hematologic cancer	0.000164	0.000372	CcSEcCtD
Carbachol—Nausea—Irinotecan—hematologic cancer	0.000163	0.00037	CcSEcCtD
Carbachol—Nausea—Mitoxantrone—hematologic cancer	0.000163	0.00037	CcSEcCtD
Carbachol—Infection—Prednisone—hematologic cancer	0.000163	0.000369	CcSEcCtD
Carbachol—Shock—Prednisone—hematologic cancer	0.000161	0.000365	CcSEcCtD
Carbachol—Arrhythmia—Epirubicin—hematologic cancer	0.000161	0.000365	CcSEcCtD
Carbachol—Pain—Dexamethasone—hematologic cancer	0.000161	0.000365	CcSEcCtD
Carbachol—Pain—Betamethasone—hematologic cancer	0.000161	0.000365	CcSEcCtD
Carbachol—Nausea—Gemcitabine—hematologic cancer	0.000159	0.00036	CcSEcCtD
Carbachol—Vomiting—Cisplatin—hematologic cancer	0.000159	0.00036	CcSEcCtD
Carbachol—Hyperhidrosis—Prednisone—hematologic cancer	0.000158	0.000359	CcSEcCtD
Carbachol—Rash—Cisplatin—hematologic cancer	0.000157	0.000357	CcSEcCtD
Carbachol—Dermatitis—Cisplatin—hematologic cancer	0.000157	0.000356	CcSEcCtD
Carbachol—Diarrhoea—Etoposide—hematologic cancer	0.000156	0.000355	CcSEcCtD
Carbachol—Flushing—Doxorubicin—hematologic cancer	0.000155	0.000351	CcSEcCtD
Carbachol—Flatulence—Epirubicin—hematologic cancer	0.000155	0.000351	CcSEcCtD
Carbachol—Dizziness—Etoposide—hematologic cancer	0.000151	0.000343	CcSEcCtD
Carbachol—Muscle spasms—Epirubicin—hematologic cancer	0.000151	0.000342	CcSEcCtD
Carbachol—Dizziness—Prednisolone—hematologic cancer	0.000149	0.000338	CcSEcCtD
Carbachol—Arrhythmia—Doxorubicin—hematologic cancer	0.000149	0.000338	CcSEcCtD
Carbachol—Abdominal pain—Betamethasone—hematologic cancer	0.000149	0.000337	CcSEcCtD
Carbachol—Abdominal pain—Dexamethasone—hematologic cancer	0.000149	0.000337	CcSEcCtD
Carbachol—Body temperature increased—Dexamethasone—hematologic cancer	0.000149	0.000337	CcSEcCtD
Carbachol—Body temperature increased—Betamethasone—hematologic cancer	0.000149	0.000337	CcSEcCtD
Carbachol—Nausea—Cisplatin—hematologic cancer	0.000148	0.000336	CcSEcCtD
Carbachol—Vomiting—Etoposide—hematologic cancer	0.000145	0.000329	CcSEcCtD
Carbachol—Dyspepsia—Prednisone—hematologic cancer	0.000144	0.000327	CcSEcCtD
Carbachol—Rash—Etoposide—hematologic cancer	0.000144	0.000327	CcSEcCtD
Carbachol—Dermatitis—Etoposide—hematologic cancer	0.000144	0.000326	CcSEcCtD
Carbachol—Headache—Etoposide—hematologic cancer	0.000143	0.000325	CcSEcCtD
Carbachol—Flatulence—Doxorubicin—hematologic cancer	0.000143	0.000324	CcSEcCtD
Carbachol—Rash—Prednisolone—hematologic cancer	0.000142	0.000322	CcSEcCtD
Carbachol—Dermatitis—Prednisolone—hematologic cancer	0.000142	0.000322	CcSEcCtD
Carbachol—Headache—Prednisolone—hematologic cancer	0.000141	0.00032	CcSEcCtD
Carbachol—Syncope—Epirubicin—hematologic cancer	0.000141	0.000319	CcSEcCtD
Carbachol—Muscle spasms—Doxorubicin—hematologic cancer	0.00014	0.000317	CcSEcCtD
Carbachol—Loss of consciousness—Epirubicin—hematologic cancer	0.000138	0.000313	CcSEcCtD
Carbachol—Dizziness—Triamcinolone—hematologic cancer	0.000137	0.000311	CcSEcCtD
Carbachol—Infection—Methotrexate—hematologic cancer	0.000136	0.000308	CcSEcCtD
Carbachol—Nausea—Etoposide—hematologic cancer	0.000136	0.000308	CcSEcCtD
Carbachol—Nausea—Prednisolone—hematologic cancer	0.000134	0.000304	CcSEcCtD
Carbachol—Hyperhidrosis—Methotrexate—hematologic cancer	0.000132	0.0003	CcSEcCtD
Carbachol—Vomiting—Triamcinolone—hematologic cancer	0.000132	0.000299	CcSEcCtD
Carbachol—Rash—Triamcinolone—hematologic cancer	0.000131	0.000296	CcSEcCtD
Carbachol—Dermatitis—Triamcinolone—hematologic cancer	0.000131	0.000296	CcSEcCtD
Carbachol—Syncope—Doxorubicin—hematologic cancer	0.00013	0.000295	CcSEcCtD
Carbachol—Headache—Triamcinolone—hematologic cancer	0.00013	0.000294	CcSEcCtD
Carbachol—Body temperature increased—Prednisone—hematologic cancer	0.00013	0.000294	CcSEcCtD
Carbachol—Abdominal pain—Prednisone—hematologic cancer	0.00013	0.000294	CcSEcCtD
Carbachol—Diarrhoea—Dexamethasone—hematologic cancer	0.000129	0.000292	CcSEcCtD
Carbachol—Diarrhoea—Betamethasone—hematologic cancer	0.000129	0.000292	CcSEcCtD
Carbachol—Hypotension—Methotrexate—hematologic cancer	0.000128	0.00029	CcSEcCtD
Carbachol—Loss of consciousness—Doxorubicin—hematologic cancer	0.000128	0.000289	CcSEcCtD
Carbachol—Infection—Epirubicin—hematologic cancer	0.000127	0.000289	CcSEcCtD
Carbachol—Shock—Epirubicin—hematologic cancer	0.000126	0.000286	CcSEcCtD
Carbachol—Dizziness—Betamethasone—hematologic cancer	0.000124	0.000282	CcSEcCtD
Carbachol—Dizziness—Dexamethasone—hematologic cancer	0.000124	0.000282	CcSEcCtD
Carbachol—Hyperhidrosis—Epirubicin—hematologic cancer	0.000124	0.000281	CcSEcCtD
Carbachol—Nausea—Triamcinolone—hematologic cancer	0.000123	0.000279	CcSEcCtD
Carbachol—Dyspepsia—Methotrexate—hematologic cancer	0.000121	0.000273	CcSEcCtD
Carbachol—Hypotension—Epirubicin—hematologic cancer	0.00012	0.000271	CcSEcCtD
Carbachol—Vomiting—Dexamethasone—hematologic cancer	0.00012	0.000271	CcSEcCtD
Carbachol—Vomiting—Betamethasone—hematologic cancer	0.00012	0.000271	CcSEcCtD
Carbachol—Rash—Dexamethasone—hematologic cancer	0.000119	0.000269	CcSEcCtD
Carbachol—Rash—Betamethasone—hematologic cancer	0.000119	0.000269	CcSEcCtD
Carbachol—Dermatitis—Betamethasone—hematologic cancer	0.000119	0.000269	CcSEcCtD
Carbachol—Dermatitis—Dexamethasone—hematologic cancer	0.000119	0.000269	CcSEcCtD
Carbachol—Headache—Dexamethasone—hematologic cancer	0.000118	0.000267	CcSEcCtD
Carbachol—Headache—Betamethasone—hematologic cancer	0.000118	0.000267	CcSEcCtD
Carbachol—Infection—Doxorubicin—hematologic cancer	0.000118	0.000267	CcSEcCtD
Carbachol—Pain—Methotrexate—hematologic cancer	0.000117	0.000265	CcSEcCtD
Carbachol—Shock—Doxorubicin—hematologic cancer	0.000117	0.000264	CcSEcCtD
Carbachol—Hyperhidrosis—Doxorubicin—hematologic cancer	0.000115	0.00026	CcSEcCtD
Carbachol—Dyspepsia—Epirubicin—hematologic cancer	0.000113	0.000256	CcSEcCtD
Carbachol—Diarrhoea—Prednisone—hematologic cancer	0.000112	0.000254	CcSEcCtD
Carbachol—Nausea—Betamethasone—hematologic cancer	0.000112	0.000253	CcSEcCtD
Carbachol—Nausea—Dexamethasone—hematologic cancer	0.000112	0.000253	CcSEcCtD
Carbachol—Hypotension—Doxorubicin—hematologic cancer	0.000111	0.000251	CcSEcCtD
Carbachol—Pain—Epirubicin—hematologic cancer	0.00011	0.000248	CcSEcCtD
Carbachol—Dizziness—Prednisone—hematologic cancer	0.000108	0.000246	CcSEcCtD
Carbachol—Abdominal pain—Methotrexate—hematologic cancer	0.000108	0.000245	CcSEcCtD
Carbachol—Body temperature increased—Methotrexate—hematologic cancer	0.000108	0.000245	CcSEcCtD
Carbachol—Dyspepsia—Doxorubicin—hematologic cancer	0.000104	0.000237	CcSEcCtD
Carbachol—Vomiting—Prednisone—hematologic cancer	0.000104	0.000236	CcSEcCtD
Carbachol—Rash—Prednisone—hematologic cancer	0.000103	0.000234	CcSEcCtD
Carbachol—Dermatitis—Prednisone—hematologic cancer	0.000103	0.000234	CcSEcCtD
Carbachol—Headache—Prednisone—hematologic cancer	0.000103	0.000233	CcSEcCtD
Carbachol—Pain—Doxorubicin—hematologic cancer	0.000101	0.00023	CcSEcCtD
Carbachol—Body temperature increased—Epirubicin—hematologic cancer	0.000101	0.00023	CcSEcCtD
Carbachol—Abdominal pain—Epirubicin—hematologic cancer	0.000101	0.00023	CcSEcCtD
Carbachol—Nausea—Prednisone—hematologic cancer	9.74e-05	0.000221	CcSEcCtD
Carbachol—Abdominal pain—Doxorubicin—hematologic cancer	9.38e-05	0.000212	CcSEcCtD
Carbachol—Body temperature increased—Doxorubicin—hematologic cancer	9.38e-05	0.000212	CcSEcCtD
Carbachol—Diarrhoea—Methotrexate—hematologic cancer	9.37e-05	0.000212	CcSEcCtD
Carbachol—Dizziness—Methotrexate—hematologic cancer	9.06e-05	0.000205	CcSEcCtD
Carbachol—Diarrhoea—Epirubicin—hematologic cancer	8.77e-05	0.000199	CcSEcCtD
Carbachol—Vomiting—Methotrexate—hematologic cancer	8.71e-05	0.000197	CcSEcCtD
Carbachol—Rash—Methotrexate—hematologic cancer	8.64e-05	0.000196	CcSEcCtD
Carbachol—Dermatitis—Methotrexate—hematologic cancer	8.63e-05	0.000196	CcSEcCtD
Carbachol—Headache—Methotrexate—hematologic cancer	8.58e-05	0.000194	CcSEcCtD
Carbachol—Dizziness—Epirubicin—hematologic cancer	8.48e-05	0.000192	CcSEcCtD
Carbachol—Vomiting—Epirubicin—hematologic cancer	8.15e-05	0.000185	CcSEcCtD
Carbachol—Nausea—Methotrexate—hematologic cancer	8.14e-05	0.000184	CcSEcCtD
Carbachol—Diarrhoea—Doxorubicin—hematologic cancer	8.12e-05	0.000184	CcSEcCtD
Carbachol—Rash—Epirubicin—hematologic cancer	8.08e-05	0.000183	CcSEcCtD
Carbachol—Dermatitis—Epirubicin—hematologic cancer	8.08e-05	0.000183	CcSEcCtD
Carbachol—Headache—Epirubicin—hematologic cancer	8.03e-05	0.000182	CcSEcCtD
Carbachol—Dizziness—Doxorubicin—hematologic cancer	7.84e-05	0.000178	CcSEcCtD
Carbachol—Nausea—Epirubicin—hematologic cancer	7.61e-05	0.000173	CcSEcCtD
Carbachol—Vomiting—Doxorubicin—hematologic cancer	7.54e-05	0.000171	CcSEcCtD
Carbachol—Rash—Doxorubicin—hematologic cancer	7.48e-05	0.000169	CcSEcCtD
Carbachol—Dermatitis—Doxorubicin—hematologic cancer	7.47e-05	0.000169	CcSEcCtD
Carbachol—Headache—Doxorubicin—hematologic cancer	7.43e-05	0.000168	CcSEcCtD
Carbachol—Nausea—Doxorubicin—hematologic cancer	7.05e-05	0.00016	CcSEcCtD
Carbachol—CHRM1—Signaling Pathways—FGF1—hematologic cancer	1.57e-05	8.15e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—NCOR1—hematologic cancer	1.57e-05	8.14e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CSF2—hematologic cancer	1.57e-05	8.13e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—FGF1—hematologic cancer	1.57e-05	8.13e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—PTEN—hematologic cancer	1.55e-05	8.07e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—PIK3CA—hematologic cancer	1.55e-05	8.06e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CSF2—hematologic cancer	1.55e-05	8.05e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—FGF1—hematologic cancer	1.55e-05	8.05e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—FOXO1—hematologic cancer	1.55e-05	8.04e-05	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—IL2—hematologic cancer	1.55e-05	8.03e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—MDM2—hematologic cancer	1.55e-05	8.02e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PDGFRB—hematologic cancer	1.55e-05	8.02e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—FOXO1—hematologic cancer	1.54e-05	8.01e-05	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—IL2—hematologic cancer	1.54e-05	8.01e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PDGFRB—hematologic cancer	1.54e-05	8e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—PIK3CB—hematologic cancer	1.53e-05	7.94e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—FOXO1—hematologic cancer	1.53e-05	7.93e-05	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—IL2—hematologic cancer	1.53e-05	7.93e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PDGFRB—hematologic cancer	1.53e-05	7.92e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—PIK3CB—hematologic cancer	1.53e-05	7.92e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PDGFRA—hematologic cancer	1.52e-05	7.9e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PDGFRA—hematologic cancer	1.52e-05	7.87e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—JAK1—hematologic cancer	1.52e-05	7.87e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PRKCG—hematologic cancer	1.52e-05	7.87e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PRKCG—hematologic cancer	1.51e-05	7.84e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—JAK1—hematologic cancer	1.51e-05	7.84e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—PIK3CB—hematologic cancer	1.51e-05	7.84e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—PIK3CB—hematologic cancer	1.5e-05	7.81e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—MTOR—hematologic cancer	1.5e-05	7.81e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PDGFRA—hematologic cancer	1.5e-05	7.8e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—JAK1—hematologic cancer	1.5e-05	7.77e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PRKCG—hematologic cancer	1.5e-05	7.77e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—EP300—hematologic cancer	1.48e-05	7.69e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—HRAS—hematologic cancer	1.44e-05	7.45e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—IL2RA—hematologic cancer	1.42e-05	7.35e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CDKN1B—hematologic cancer	1.41e-05	7.33e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—IL2RA—hematologic cancer	1.41e-05	7.33e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PIK3CG—hematologic cancer	1.41e-05	7.3e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—IL2—hematologic cancer	1.41e-05	7.29e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—IL2—hematologic cancer	1.4e-05	7.27e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—TERT—hematologic cancer	1.4e-05	7.27e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—IL2RA—hematologic cancer	1.4e-05	7.26e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—TERT—hematologic cancer	1.4e-05	7.24e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—IL2—hematologic cancer	1.39e-05	7.2e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CASP3—hematologic cancer	1.38e-05	7.18e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—TERT—hematologic cancer	1.38e-05	7.17e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—IL2—hematologic cancer	1.38e-05	7.17e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—IL6—hematologic cancer	1.37e-05	7.13e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PDGFB—hematologic cancer	1.37e-05	7.09e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PDGFB—hematologic cancer	1.36e-05	7.07e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PDGFB—hematologic cancer	1.35e-05	7e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CCND1—hematologic cancer	1.35e-05	6.99e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—JUN—hematologic cancer	1.34e-05	6.97e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—TSC2—hematologic cancer	1.34e-05	6.93e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—TSC2—hematologic cancer	1.33e-05	6.91e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—TSC2—hematologic cancer	1.32e-05	6.84e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—CREBBP—hematologic cancer	1.3e-05	6.77e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CDKN1A—hematologic cancer	1.3e-05	6.76e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—PTEN—hematologic cancer	1.3e-05	6.75e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—FGFR3—hematologic cancer	1.29e-05	6.67e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—FGFR3—hematologic cancer	1.28e-05	6.65e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MAPK14—hematologic cancer	1.27e-05	6.6e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—MAPK8—hematologic cancer	1.27e-05	6.6e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—FGFR3—hematologic cancer	1.27e-05	6.58e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MAPK14—hematologic cancer	1.27e-05	6.58e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—AKT1—hematologic cancer	1.27e-05	6.58e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MAPK14—hematologic cancer	1.26e-05	6.52e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—ESR1—hematologic cancer	1.25e-05	6.48e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—ESR1—hematologic cancer	1.24e-05	6.46e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—EP300—hematologic cancer	1.24e-05	6.43e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PIK3CD—hematologic cancer	1.24e-05	6.42e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—FN1—hematologic cancer	1.23e-05	6.4e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—ESR1—hematologic cancer	1.23e-05	6.39e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—FN1—hematologic cancer	1.23e-05	6.38e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—ALB—hematologic cancer	1.22e-05	6.33e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—NFKBIA—hematologic cancer	1.22e-05	6.32e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—BAD—hematologic cancer	1.22e-05	6.32e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—FN1—hematologic cancer	1.22e-05	6.32e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—BAD—hematologic cancer	1.21e-05	6.3e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—NFKBIA—hematologic cancer	1.21e-05	6.3e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—NOTCH1—hematologic cancer	1.21e-05	6.26e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—SRC—hematologic cancer	1.21e-05	6.26e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—NOTCH1—hematologic cancer	1.2e-05	6.24e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—BAD—hematologic cancer	1.2e-05	6.24e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—NFKBIA—hematologic cancer	1.2e-05	6.24e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—NOTCH1—hematologic cancer	1.19e-05	6.18e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CD80—hematologic cancer	1.18e-05	6.13e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—KIT—hematologic cancer	1.18e-05	6.12e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PIK3CG—hematologic cancer	1.18e-05	6.12e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—NRAS—hematologic cancer	1.18e-05	6.12e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CD80—hematologic cancer	1.18e-05	6.11e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PIK3CG—hematologic cancer	1.18e-05	6.1e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—KIT—hematologic cancer	1.18e-05	6.1e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—NRAS—hematologic cancer	1.18e-05	6.1e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—VEGFA—hematologic cancer	1.17e-05	6.09e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PIK3R1—hematologic cancer	1.17e-05	6.06e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CD80—hematologic cancer	1.17e-05	6.06e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PIK3CG—hematologic cancer	1.16e-05	6.04e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—KIT—hematologic cancer	1.16e-05	6.04e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—NRAS—hematologic cancer	1.16e-05	6.04e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—STAT3—hematologic cancer	1.16e-05	6.03e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—NRAS—hematologic cancer	1.16e-05	6.02e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PTPN11—hematologic cancer	1.16e-05	6.02e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PTPN11—hematologic cancer	1.16e-05	6e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PTPN11—hematologic cancer	1.14e-05	5.94e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—MAPK3—hematologic cancer	1.13e-05	5.86e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—MAPK3—hematologic cancer	1.13e-05	5.85e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CREB1—hematologic cancer	1.12e-05	5.83e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CREB1—hematologic cancer	1.12e-05	5.81e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—MAPK3—hematologic cancer	1.12e-05	5.79e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—MAPK3—hematologic cancer	1.11e-05	5.76e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—BRAF—hematologic cancer	1.11e-05	5.76e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CREB1—hematologic cancer	1.11e-05	5.75e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—BRAF—hematologic cancer	1.11e-05	5.74e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CCL2—hematologic cancer	1.1e-05	5.7e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—PIK3CA—hematologic cancer	1.1e-05	5.69e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—IL6R—hematologic cancer	1.1e-05	5.69e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CCL2—hematologic cancer	1.1e-05	5.68e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—BRAF—hematologic cancer	1.09e-05	5.68e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CREBBP—hematologic cancer	1.09e-05	5.68e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—IL6R—hematologic cancer	1.09e-05	5.67e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CREBBP—hematologic cancer	1.09e-05	5.66e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CCL2—hematologic cancer	1.08e-05	5.63e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—IL6R—hematologic cancer	1.08e-05	5.61e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—MYC—hematologic cancer	1.08e-05	5.61e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CREBBP—hematologic cancer	1.08e-05	5.6e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PIK3CB—hematologic cancer	1.08e-05	5.59e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—TGFB1—hematologic cancer	1.08e-05	5.59e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MAP2K1—hematologic cancer	1.04e-05	5.42e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MAP2K1—hematologic cancer	1.04e-05	5.4e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PIK3CD—hematologic cancer	1.04e-05	5.38e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PIK3CD—hematologic cancer	1.03e-05	5.37e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MAP2K1—hematologic cancer	1.03e-05	5.35e-05	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—PIK3CA—hematologic cancer	1.03e-05	5.33e-05	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—PIK3CA—hematologic cancer	1.02e-05	5.31e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PIK3CD—hematologic cancer	1.02e-05	5.31e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—KRAS—hematologic cancer	1.02e-05	5.27e-05	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—PIK3CA—hematologic cancer	1.01e-05	5.26e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—KRAS—hematologic cancer	1.01e-05	5.25e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—KRAS—hematologic cancer	1e-05	5.2e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—KRAS—hematologic cancer	9.98e-06	5.18e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—FGF2—hematologic cancer	9.93e-06	5.15e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—FGF2—hematologic cancer	9.9e-06	5.14e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—FGF2—hematologic cancer	9.81e-06	5.09e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PIK3R1—hematologic cancer	9.8e-06	5.08e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PIK3R1—hematologic cancer	9.76e-06	5.07e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PIK3R1—hematologic cancer	9.67e-06	5.02e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—JAK2—hematologic cancer	9.52e-06	4.94e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—JAK2—hematologic cancer	9.49e-06	4.92e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—JAK2—hematologic cancer	9.4e-06	4.88e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—PIK3CA—hematologic cancer	9.33e-06	4.84e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PTEN—hematologic cancer	9.31e-06	4.83e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—PIK3CA—hematologic cancer	9.3e-06	4.83e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MDM2—hematologic cancer	9.29e-06	4.82e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MDM2—hematologic cancer	9.26e-06	4.81e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—PIK3CA—hematologic cancer	9.21e-06	4.78e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MDM2—hematologic cancer	9.17e-06	4.76e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—PIK3CA—hematologic cancer	9.17e-06	4.76e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PIK3CB—hematologic cancer	9.04e-06	4.69e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MTOR—hematologic cancer	9.04e-06	4.69e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PIK3CB—hematologic cancer	9.01e-06	4.68e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MTOR—hematologic cancer	9.01e-06	4.68e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—AKT1—hematologic cancer	8.96e-06	4.65e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MTOR—hematologic cancer	8.93e-06	4.63e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PIK3CB—hematologic cancer	8.93e-06	4.63e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—EP300—hematologic cancer	8.88e-06	4.61e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—TP53—hematologic cancer	8.87e-06	4.6e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—HRAS—hematologic cancer	8.63e-06	4.48e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—HRAS—hematologic cancer	8.61e-06	4.47e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—HRAS—hematologic cancer	8.52e-06	4.42e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—HRAS—hematologic cancer	8.49e-06	4.4e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CDKN1B—hematologic cancer	8.49e-06	4.4e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CDKN1B—hematologic cancer	8.46e-06	4.39e-05	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—AKT1—hematologic cancer	8.39e-06	4.36e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CDKN1B—hematologic cancer	8.38e-06	4.35e-05	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—AKT1—hematologic cancer	8.37e-06	4.34e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CASP3—hematologic cancer	8.32e-06	4.32e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—IL2—hematologic cancer	8.3e-06	4.31e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CASP3—hematologic cancer	8.29e-06	4.3e-05	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—AKT1—hematologic cancer	8.29e-06	4.3e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—IL2—hematologic cancer	8.28e-06	4.3e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—IL6—hematologic cancer	8.26e-06	4.29e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—IL6—hematologic cancer	8.24e-06	4.27e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CASP3—hematologic cancer	8.21e-06	4.26e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—IL2—hematologic cancer	8.2e-06	4.25e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—IL6—hematologic cancer	8.16e-06	4.23e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—IL6—hematologic cancer	8.12e-06	4.21e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CCND1—hematologic cancer	8.1e-06	4.2e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—JUN—hematologic cancer	8.08e-06	4.19e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CCND1—hematologic cancer	8.07e-06	4.19e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—JUN—hematologic cancer	8.05e-06	4.18e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CCND1—hematologic cancer	7.99e-06	4.15e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—JUN—hematologic cancer	7.97e-06	4.14e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CDKN1A—hematologic cancer	7.83e-06	4.06e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PTEN—hematologic cancer	7.81e-06	4.05e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CDKN1A—hematologic cancer	7.81e-06	4.05e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PTEN—hematologic cancer	7.79e-06	4.04e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CDKN1A—hematologic cancer	7.73e-06	4.01e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PTEN—hematologic cancer	7.71e-06	4e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MAPK8—hematologic cancer	7.64e-06	3.97e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—AKT1—hematologic cancer	7.62e-06	3.96e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MAPK8—hematologic cancer	7.62e-06	3.95e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—AKT1—hematologic cancer	7.6e-06	3.94e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MAPK8—hematologic cancer	7.55e-06	3.92e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—AKT1—hematologic cancer	7.52e-06	3.9e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—AKT1—hematologic cancer	7.49e-06	3.89e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—EP300—hematologic cancer	7.45e-06	3.87e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—EP300—hematologic cancer	7.43e-06	3.85e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—EP300—hematologic cancer	7.36e-06	3.82e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—SRC—hematologic cancer	7.25e-06	3.76e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—SRC—hematologic cancer	7.22e-06	3.75e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—SRC—hematologic cancer	7.15e-06	3.71e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—VEGFA—hematologic cancer	7.06e-06	3.66e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—VEGFA—hematologic cancer	7.04e-06	3.65e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—STAT3—hematologic cancer	6.99e-06	3.63e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—NRAS—hematologic cancer	6.97e-06	3.62e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—VEGFA—hematologic cancer	6.97e-06	3.61e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—STAT3—hematologic cancer	6.97e-06	3.61e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—NRAS—hematologic cancer	6.95e-06	3.61e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—STAT3—hematologic cancer	6.9e-06	3.58e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—NRAS—hematologic cancer	6.88e-06	3.57e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MAPK3—hematologic cancer	6.68e-06	3.46e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MAPK3—hematologic cancer	6.65e-06	3.45e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MAPK3—hematologic cancer	6.59e-06	3.42e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PIK3CA—hematologic cancer	6.57e-06	3.41e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MYC—hematologic cancer	6.49e-06	3.37e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—TGFB1—hematologic cancer	6.48e-06	3.36e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MYC—hematologic cancer	6.47e-06	3.36e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—TGFB1—hematologic cancer	6.46e-06	3.35e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MYC—hematologic cancer	6.41e-06	3.33e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—TGFB1—hematologic cancer	6.39e-06	3.32e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—KRAS—hematologic cancer	6e-06	3.11e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—KRAS—hematologic cancer	5.98e-06	3.1e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—KRAS—hematologic cancer	5.92e-06	3.07e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PIK3CA—hematologic cancer	5.51e-06	2.86e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PIK3CA—hematologic cancer	5.49e-06	2.85e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PIK3CA—hematologic cancer	5.44e-06	2.82e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—AKT1—hematologic cancer	5.37e-06	2.79e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—TP53—hematologic cancer	5.33e-06	2.77e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—TP53—hematologic cancer	5.32e-06	2.76e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—TP53—hematologic cancer	5.26e-06	2.73e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—HRAS—hematologic cancer	5.1e-06	2.65e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—HRAS—hematologic cancer	5.08e-06	2.64e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—HRAS—hematologic cancer	5.03e-06	2.61e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—IL6—hematologic cancer	4.88e-06	2.53e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—IL6—hematologic cancer	4.87e-06	2.52e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—IL6—hematologic cancer	4.82e-06	2.5e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—AKT1—hematologic cancer	4.5e-06	2.34e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—AKT1—hematologic cancer	4.49e-06	2.33e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—AKT1—hematologic cancer	4.45e-06	2.31e-05	CbGpPWpGaD
